Telix Pharmaceuticals Limited (Premium)



Ticker code: ASX:TNE

ASX:TNE Red Flags & Risk Indicators
⚠️
⚠️ RED FLAGS: 1 identified

  • High Relative Valuation

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
1.55468 1.82058 2.0918 17.1 14.9 0.66191 0.78599 0.92794 18.7 18.1
ASX:TNE Revenue Per Share (2012–2027)
Telix Pharmaceuticals Limited (ASX:TNE) Revenue Chart 2012–2027
ASX:TNE Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
Telix Pharmaceuticals Limited (ASX:TNE) EBITDA Chart 2012–2027
ASX:TNE Normalised Earnings Per Share (EPS) (2012–2027)
Telix Pharmaceuticals Limited (ASX:TNE) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
22.8 30.2 120.1 106.7 29.2 91.5 43.3 76.8 22/8/25
ASX:TNE Yearly Price Earnings Ratio (PER) Highs and Lows
Telix Pharmaceuticals Limited (ASX:TNE) PER Highs and Lows (2012–2027)
ASX:TNE Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Telix Pharmaceuticals Limited (ASX:TNE) 10-Year Weekly ATR Trailing Stop Price Chart


Leave a Reply

Your email address will not be published. Required fields are marked *